gcolor="#ffffff" align="center" colspan="2"|
polymyxin E |
| lign="center" colspan="2" style="border-bottom:3px solid gray"| IUPAC name ? |
lign="center" style="border-bottom: 3px solid gray"| CAS number
? | align="center" style="border-bottom: 3px solid gray"| ATC code
A07AA10 / J01XB01 |
| gcolor="#efefef"|Chemical formula | bgcolor="#dfefff"| |
| gcolor="#efefef"|Molecular weight | bgcolor="#dfefff"|x |
| gcolor="#efefef"|Bioavailability | bgcolor="#dfefff"|? |
| gcolor="#efefef"|Metabolism | bgcolor="#dfefff"|? |
| gcolor="#efefef"|Elimination half life | bgcolor="#dfefff"|5 hours |
| gcolor="#efefef"|Excretion | bgcolor="#dfefff"| urine
|
| gcolor="#efefef"| Pregnancy category | bgcolor="#dfefff"|? (USA)
B2 (Aus) |
| gcolor="#efefef"|Delivery | bgcolor="#dfefff"|topical, oral,intravenous or intramuscular injection, otic suspension, inhalation |
gcolor="#ffffff" align="left" colspan="2"| Indicated for:
|
gcolor="#ffffff" align="left" colspan="2"| Contraindications:
|
gcolor="#ffffff" align="left" colspan="2"| Side effects:
Atypical sensations: - sensory disturbances of face and extremities
Cardiovascular: Ear, nose, and throat: Gastrointestinal: Muscular: - pain following i.m. injection
Neurological: Respiratory: Skin: Miscellaneous: |